• Rezultati Niso Bili Najdeni

1. International Agency for research on Cancer, Globocan 2020, https://gco.iarc.fr/today/data/factsheets/cancers/7-Stomach-fact-sheet.pdf

(dostopno: 24. 6. 2021)

2. International Agency for research on Cancer, Slovenia Fact Sheet, Stomach Cancer, https://gco.iarc.fr/today/data/factsheets/populations/705-slovenia-fact-sheets.pdf (dostopno: 24. 6. 2021)

3. de Martel C, Forman D, Plummer M: Gastric cancer: Epidemiology and risk factors. Gastroenterol Clin North Am. 2013;42:219–240

4. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 61., Schistosomes, Liver flukes and Helicobacter pylori, 1994, https://www.ncbi.nlm.nih.gov/books/NBK487780/(dostopno: 8. 4. 2020)

5. Plummer M, Franceschi S, Vignat J, Forman D, de Martel C: Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer 2015,136(2):487-490 6. Kim S. S, Ruiz V. E, Carroll J. D, Moss S. F: Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett. 2011;305:228–


7. National Cancer Institute, The Cancer Genome Atlas,

https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/studied-cancers/stomach (dostopno: 2. 5. 2020)

8. Sun K, Jia K, Lv H, Wang S-Q, Wu Y, Lei H, Chen X: EBV-Positive Gastric Cancer: Current Knowledge and Future Perspectives. Frontiers in Oncology 2020;10:2096

9. Hohenberger P, Gretschel S: Gastric cancer. Lancet 2003; 362: 305-315

10. Pounder R. E, Ng D: The prevalence of Helicobacter pylori infection in different countries. Alimentary Pharmacology & Therapeutics 1995 ;9 Suppl 2:33-39

11. Maehara Y, Watanabe A, Kakeji Y, Emi Y, Moriguchi S, Anai H, Sugimachi K:

Prognosis for surgically treated gastric cancer patients is poorer for women than men in all patients under age 50. Br J Cancer 1992; 65 (3): 417-420

12. Milne N. A, Sitarz R, Carvalho R, Carneiro F, Offerhaus G. J: Early Onset Gastric Cancer: On the Road to Unraveling Gastric Carcinogenesis. Current Molecular Medicine 2007; 7: 15

13. Huntsman D G, Carneiro F, Lewis F R, MacLeod P M, Hayashi A, Monaghan K G, Maung R, Seruca R, Jackson C E, Caldas C: Early Gastric Cancer in Young,


Asymptomatic Carriers of Germ-Line E-Cadherin Mutations. N Engl J Med 2001;

344: 1904-1909

14. Burkitt M D, Varro A, Pritchard M D: Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol 2009; 15 (1): 1-16

15. Schubert M L: Gastric secretion. Current Opinion in Gastroenterology 2010;26:


16. Dockray G J,Varro A, Dimaline R, Wang T: The Gastrins: Their Production and Biological Activities. Annu Rev Physiol 2001;63(1):119–139

17. Grabowska A M, Watson S A: Role of gastin peptides in carcinogenesis. Cancer Letters 2007; 257 (1):1–15

18. Behe M, Behr T M: Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies. Biopolymers 2002; 66 (6): 399–418

19. Smith J P, Shih A H, Wotring M G, McLaughlin P J, Zagon I S: Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma. Int J Oncol 1998; 12 (2):


20. Henwood M, Clarke P A, Smith A M, Watson S A: Expression of gastrin in developing gastric adenocarcinoma. Br J Surg 2001; 88 (4): 564-568

21. Sawaoka H, Kawano S, Tsuji S, Tsuji M, Sun W, Gunawan E S, Hori M:

Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukot Essent Fatty Acids 1998;59(5):313-316 22. Ristimäki A, Honkanen N, Jänkälä H, Sipponen P, Härkönen M: Expression of

Cyclooxygenase-2 in Human Gastric Carcinoma. Cancer Res 1997;57(7):1276 23. Baldwin G S: The role of gastrin and cholecystokinin in normal and neoplastic

gastrointestinal growth. Journal of Gastroenterology and Hepatology 1995; 10:


24. Delle Fave G, Marignani M, Moretti A, D'Ambra G, Martino G, Annibale B:

Hypergastrinemia and enterochromaffin-like cell hyperplasia. Yale J Biol Med 1998;71(3-4):291‐301

25. Sun W H, Sun Y L, Fang R N, Shao Y, Xu H C, Xue Q P, Ding G X, Cheng Y L:

Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-9 in Gastric Carcinoma and its Correlation with Angiogenesis. Japanese Journal of Clinical Oncology 2005; 35(12):707–713


26. Konturek P C, Rembiasz K, Konturek J S, Stachura J, Bielanski W, Galuschka K, Karcz D, Hahn E G: Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Dig Dis Sci 2003; 48(1):36-46

27. Sun W H, Zhu F, Chen G S, Su H, Luo C, Zhao Q S, Zhang Y, Shao Y, Sun J, Zhou S M, Ding G X, Cheng Y L: Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis, and inhibits the proliferation of human gastric cancer cells in vitro. Cancer Lett 2008; 263 (2): 302-311

28. Ferrand A, Kowalski-Chauvel A, Bertrand C, Pradayrol L, Fourmy D, Dufresne M, Seva C: Involvement of JAK2 upstream of the PI 3-kinase in cell-cell adhesion regulation by gastrin. Exp Cell Res 2004; 301(2):128-138

29. Wroblewski L E, Pritchard D M, Carter S, Varro A: Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression. The Biochemical Journal 2002; 365(3):873-879 30. Dulak A M, Schumacher S E, van Lieshout J, Imamura Y, Fox C, Shim B, Ramos

A H, Saksena G, Baca S C, Baselga J, Tabernero J, Barretina J, Enzinger P C, Corso G, Roviello F, Lin L, Bandla S, Luketich J D, Pennathur A, Meyerson M, Ogino S, Shivdasani R A, Beer D G, Godfrey T E, Beroukhim R, Bass A J:

Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res 2012;72(17):4383–4393

31. Kim M A, Lee H S, Lee H E, Jeon Y K, Yang H K, Kim W H: EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology 2008;52(6):738-746

32. Tokunaga A, Onda M, Okuda T, Teramoto T, Fujita I, Mizutani T, Kiyama T, Yoshiyuki T, Nishi K, Matsukura N: Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. Cancer 1995;75(6 Suppl):1418-1425

33. Noble P J M, Wilde G, White M R H, Pennington S R, Dockray G J, Varro A:

Stimulation of gastrin-CCKB receptor promotes migration of gastric AGS cells via multiple paracrine pathways. American Journal of Physiology-Gastrointestinal and Liver Physiology 2003;284(1):G75–84


34. Pisitkun T, Shen R F, Knepper M A: Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004;101(36):13368–13373 35. Théry C, Théry C, Boussac M, Véron P, Ricciardi-Castagnoli P, Raposo G, Garin J,

Amigorena S: Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles. J Immunol 2001; 166 (12): 7309-7318

36. Van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf–Bensussan N, Heyman M: Intestinal epithelial cells secrete exosome–like vesicles.

Gastroenterology 2001;121(2):337–349

37. Bard M P, Hegmans J P, Hemmes A, Luider T M, Willemsen R, Severijnen L-A A, van Meerbeeck J P, Burgers S A, Hoogsteden H C, Lambrecht B N: Proteomic Analysis of Exosomes Isolated from Human Malignant Pleural Effusions. Am J Respir Cell Mol Biol 2004;31(1):114–121

38. Admyre C, Grunewald J, Thyberg J, Gripenbäck S, Tornling G, Eklund A, Scheynius A, Gabrielsson S: Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J 2003; 22(4):578

39. Keller S, Ridinger J, Rupp A K, Janssen J W, Altevogt P: Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 2011; 9:86 40. Ferdin J, Lenassi M: Zunajcelični vezikli in njihov bioklinični potencial. Med

Razgl 2016; 55 (1): 63–82

41. Mathivanan S, Fahner C J, Reid G E, Simpson R J: ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012; 40 (Database issue):D1241–D1244

42. Colombo M, Raposo G, Théry C: Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles. Annu Rev Cell Dev Biol 2014;30(1):255–289

43. Nanbo A, Kawanishi E, Yoshida R, Yoshiyama H: Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells. J Virol 2013;87(18):10334–10347

44. Mathivanan S, Ji H, Simpson R J. Exosomes: Extracellular organelles important in intercellular communication. Journal of Proteomics 2010;73(10):1907–1920


45. Skog J, Würdinger T, van Rijn S, Meijer D H, Gainche L, Sena-Esteves M, Curry W T Jr, Carter B S, Krichevsky A M, Breakefield X O: Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008;10 (12):1470–1476

46. DeLeo A M, Ikezu T: Extracellular Vesicle Biology in Alzheimer's Disease and Related Tauopathy. J Neuroimmune Pharmacol 2018;13(3):292-308, table 3 and 4:30, 31

47. Croese T, Furlan R: Extracellular vesicles in neurodegenerative diseases. Molecular Aspects of Medicine 2018; 60:52–61

48. Han Y, Jia L, Zheng Y, Li W: Salivary Exosomes: Emerging Roles in Systemic Disease. Int J Biol Sci 2018;14(6):633–643

49. Bjørge I M, Kim S Y, Mano J F, Kalionis B, Chrzanowski W: Extracellular vesicles, exosomes and shedding vesicles in regenerative medicine – a new paradigm for tissue repair. Biomater Sci 2017; 6(1): 60-78

50. El-Andaloussi S, Lee Y, Lakhal-Littleton S, Li J, Seow Y, Gardiner C, Alvarez-Erviti L, Sargent I L, Wood M J: Exosome-mediated delivery of siRNA in vitro and in vivo. Nature Protocols 2012;7(12):2112–2126

51. Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, Gotoh N, Kuroda M: Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.

Mol Ther 2013; 21(1):185–191

52. Kalra H, Simpson R J, Ji H, Aikawa E, Altevogt P, Askenase P, Bond V C, Borràs F E, Breakefield X, Budnik V, Buzas E, Camussi G, Clayton A: Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation.

PLOS Biology 2012; 10(12):e1001450,

https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1001450 (dostopno: 18. 4. 2020)

53. Piper R C, Katzmann D J: Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 2007;23:519–547

54. Adell M A Y, Vogel G F, Pakdel M, Müller M, Lindner H, Hess M W, Teis D:

Coordinated binding of Vps4 to ESCRT-III drives membrane neck constriction during MVB vesicle formation. J Cell Biol 2014;205(1):33–49


55. Pollet H, Conrard L, Cloos A S, Tyteca D: Plasma Membrane Lipid Domains as Platforms for Vesicle Biogenesis and Shedding? Biomolecules 2018; 8(3):94, tabela 1

56. Piper R C, Katzmann D J: Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 2007;23:519–547

57. Lu Q, Hope L W, Brasch M, Reinhard C, Cohen S N: TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. Proc Natl Acad Sci USA 2003;100(13):7626–7631

58. György B, Szabó T G, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, Nagy G, Falus A, Buzás E I: Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011; 68 (16):


59. Lima L G, Chammas R, Monteiro R Q, Moreira M E, Barcinski M A: Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Letters 2009; 283 (2):168-175 60. Hugel B, Martínez M C, Kunzelmann C, Freyssinet J-M: Membrane

Microparticles: Two Sides of the Coin. Physiology 2005;20(1):22–27

61. D’Souza-Schorey C, Chavrier P: ARF proteins: roles in membrane traffic and beyond. Nature Reviews Molecular Cell Biology 2006;7(5):347–358

62. Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, D'Souza-Schorey C: ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 2009;19(22):1875–1885

63. Heijnen H F G, Schiel A E, Fijnheer R, Geuze H J, Sixma J J: Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and α-Granules.

Blood 1999;94(11):3791–3799

64. Zöller M: Tetraspanins: push and pull in suppressing and promoting metastasis.

Nature Reviews Cancer 2009;9(1):40–55

65. Jeppesen D K, Fenix A M, Franklin J L, Higginbotham J N, Zhang Q, Zimmerman L J, Liebler D C, Ping J, Liu Q, Evans R, Fissell W H, Patton J G, Rome L H, Burnette D T, Coffey R J: Reassessment of Exosome Composition. Cell 2019;177(2):428-445.e18


66. Théry C, Ostrowski M, Segura E: Membrane vesicles as conveyors of immune responses. Nature Reviews Immunology 2009;9(8):581–593

67. Di Vizio D, Morello M, Dudley A C, Schow P W, Adam R M, Morley S, Mulholland D, Rotinen M, Hager M H, Insabato L, Moses M A, Demichelis F, Lisanti M P, Wu H, Klagsbrun M, Bhowmick N A, Rubin M A, D'Souza-Schorey C, Freeman M R: Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol 2012;181(5):1573‐1584 68. Di Vizio D, Kim J, Hager M H, Morello M, Yang W, Lafargue C J, True L D,

Rubin MA, Adam R M, Beroukhim R, Demichelis F, Freeman M R: Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 2009;69(13):5601‐5609

69. Minciacchi V R, Freeman M R, Di Vizio D: Extracellular vesicles in cancer:

exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol 2015;40:41-51

70. Minciacchi V R, You S, Spinelli C, Morley S, Zandian M, Aspuria P J, Cavallini L, Ciardiello C, Reis Sobreiro M, Morello M, Kharmate G, Jang S C, Kim D K, Hosseini-Beheshti E, Tomlinson Guns E, Gleave M, Gho Y S, Mathivanan S, Yang W, Freeman M R, Di Vizio D: Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles.

Oncotarget 2015;6(13):11327‐11341

71. Oyama K, Fushida S, Kinoshita J, Okamoto K, Makino I, Nakamura K, Hayashi H, Inokuchi M, Nakagawara H, Tajima H, Fujita H, Takamura H, Ninomiya I, Kitagawa H, Fujimura T, Ohta T: Serum cytokeratin 18 as a biomarker for gastric cancer. Clinical and Experimental Medicine 2013;13(4):289–295

72. Coller H A: Is cancer a metabolic disease? Am J Pathol 2014;184(1):4‐17

73. Zucker S, Cao J, Chen W-T: Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000;19(56):6642–


74. Sato-Kuwabara Y, Melo S A, Soares F A, Calin G A: The fusion of two worlds:

non-coding RNAs and extracellular vesicles-diagnostic and therapeutic implications (Review). Int J Oncol 2015;46(1):17-27

75. Stec M, Szatanek R, Baj-Krzyworzeka M, Baran J, Zembala M, Barbasz J, Waligórska A, Dobrucki J W, Mytar B, Szczepanik A, Siedlar M, Drabik G,


Urbanowicz B, Zembala M: Interactions of tumour-derived micro(nano)vesicles with human gastric cancer cells. Journal of Translational Medicine 2015;13(1):376 76. Kim K M, Abdelmohsen K, Mustapic M, Kapogiannis D, Gorospe M: RNA in

extracellular vesicles. Wiley Interdiscip Rev RNA 2017;8(4)

77. Maas S L N, Breakefield X O, Weaver A M: Extracellular Vesicles: Unique Intercellular Delivery Vehicles. Trends Cell Biol 2017;27(3):172-188

78. Rocha S, Teles S P, Azevedo M, Oliveira P, Carvalho J, Oliveira C: Gastric Cancer Extracellular Vesicles Tune the Migration and Invasion of Epithelial and Mesenchymal Cells in a Histotype-Dependent Manner. Int J Mol Sci 2019;20(11):2608

79. Introduction to Nanoparticle Tracking Analysis (NTA), Measurement Principle of

ZetaView®, Particle Metrix,


metrix.de/en/technologies/nanoparticle-tracking/articles-nanoparticle-tracking/introduction-to-nanoparticle-tracking-analysis-nta (dostopno: 13. 9. 2021) 80. Zapiski vaje iz biomedicinske analitike: gradivo za interno uporabo (pretočna

citometrija). Laboratorijska biomedicina, 2. Stopnja

81. Shapiro H: Practical flow cytometry, 4. Izdaja, Wiley-Liss, New York,2003. 681 82. Flow cytometry (FACS) flourochrome selection, SinoBiological,

https://www.sinobiological.com/category/fcm-facs-fluorochrome-selection (dostopno: 13. 9. 2021)

83. Grisendi G, Finetti E, Manganaro D, Cordova N, Montagnani G, Spano C, Prapa M, Guarneri V, Otsuru S, Horwitz E M, Mari G, Dominici M: Detection of microparticles from human red blood cells by multiparametric flow cytometry.

Blood transfusion 2015, 13, 2: 274-280

84. Vesiclepedia, http://www.microvesicles.org/ (dostopno: 7. 9. 2021)

85. Théry C. et al.: Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles 2018; 7: 1535750

86. Justus C R, Leffler N, Ruiz-Echevarria M, Yang LV: In vitro cell migration and invasion assays. J Vis Exp 2014;(88):51046

87. Higginbotham J N, Demory Beckler M, Gephart J D, Franklin J L, Bogatcheva G, Kremers G J, Piston D W, Ayers G D, McConnell R E, Tyska M J, Coffey R J:


Amphiregulin exosomes increase cancer cell invasion. Curr Biol 2011;21(9):779-786

88. Wright P K, Jones S B, Ardern N, Ward R, Clarke R B, Sotgia F, Lisanti M P, Landberg G, Lamb R: 17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells. Oncotarget 2014;5(10):3055-3065 89. Lutgendorf S K, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, Rainwater K,

Ritchie J M, Yang M, Sood A K: Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 2003;9(12):4514-4521

90. Yang E V, Kim S J, Donovan E L, Chen M, Gross A C, Webster Marketon J I, Barsky S H, Glaser R: Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 2009;23(2):267-275 91. Yano S, Miwa S, Mii S, Hiroshima Y, Uehara F, Yamamoto M, Kishimoto H,

Tazawa H, Bouvet M, Fujiwara T, Hoffman R M: Invading cancer cells are predominantly in G0/G1 resulting in chemoresistance demonstrated by real-time FUCCI imaging. Cell Cycle 2014;13(6):953-960

92. Abramowicz A, Widlak P, Pietrowska M: Proteomic analysis of exosomal cargo:

The challenge of high purity vesicle isolation. Molecular BioSystems 2016; 12 (5):1407–1419

93. Composition of FBS, http://www.radio.cuci.udg.mx/bch/EN/Forschung/FBS.pdf (dostopno: 13. 9. 2021)

94. Buschmann D, Kirchner B, Hermann S, Märte M, Wurmser C, Brandes F, Kotschote S, Bonin M, Steinlein O K, Pfaffl M W, Schelling G, Reithmair M:

Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing. Journal of Extracellular Vesicles


95. Mahmood T, Yang P C: Western blot: technique, theory, and trouble shooting. N Am J Med Sci 2012;4(9):429-434

96. Moman R, Gupta N, Varacallo M: Physiology, Albumin. StatPearls Publishing 2021

97. Witwer K W, Buzás E I, Bemis L T, Bora A, Lässer C, Lötvall J, Nolte-´t Hoen E N, Piper M G, Sivaraman S, Skog J, Théry C, Wauben M H, Hochberg F:


Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. Journal of extracellular vesicles 2013;2:1

98. Szatanek R, Baj-Krzyworzeka M, Zimoch J, Lekka M, Siedlar M, Baran J: The Methods of Choice for Extracellular Vesicles (EVs) Characterization. Int J Mol Sci 2017;18(6):1153

99. Chandler W L, Yeung W, Tait J F: A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J Thromb Haemost 2011;9(6):1216-1624

100. van der Pol E, Hoekstra A G, Sturk A, Otto C, van Leeuwen T G, Nieuwland R: Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost 2010;8(12):2596-2607

101. Pospichalova V, Svoboda J, Dave Z, Kotrbova A, Kaiser K, Klemova D, Ilkovics L, Hampl A, Crha I, Jandakova E, Minar L, Weinberger V, Bryja V:

Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer. J Extracell Vesicles 2015;4:25530

102. Lamalice L, Le Boeuf F, Huot J: Endothelial Cell Migration During Angiogenesis. Circulation Research 2007;100(6):782–794

103. Zhuang K, Yan Y, Zhang X, Zhang J, Zhang L, Han K: Gastrin promotes the metastasis of gastric carcinoma through the beta-catenin/TCF-4 pathway. Oncol Rep 2016; 36: 1369–1376

104. Kun Z, Hanqing G, Hailing T, Yuan Y, Jun Z, Lingxia Z, Kun H, Xin Z:

Gastrin Enhances Autophagy and Promotes Gastric Carcinoma Proliferation via Inducing AMPKα. Oncol Res 2017;25(8):1399-1407

105. Yoshida K, Kyo E, Tsujino T, Sano T, Niimoto M, Tahara E: Expression of epidermal growth factor, transforming growth factor-a, and their receptor genes in human gastric carcinomas; implication for autocrine growth, Cancer Sci 1990;81:43–51

106. Wang N, Wang L, Yang Y, Gong L, Xiao B, Liu X: A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Biochem Biophys Res Commun 2017;493(3):1322-1328

107. Huang Z, Zhu D, Wu L, He M, Zhou X, Zhang L, Zhang H, Wang W, Zhu J, Cheng W, Chen Y, Fan Y, Qi L, Yin Y, Zhu W, Shu Y, Liu P: Six Serum-Based


miRNAs as Potential Diagnostic Biomarkers for Gastric Cancer. Cancer Epidemiology and Prevention Biomarkers 2017;26(2):188–196

108. Cikutović-Molina R, Herrada A A, González W, Brown N, Zúñiga L:

TASK-3 Gene Knockdown Dampens Invasion and Migration and Promotes Apoptosis in KATO III and MKN-45 Human Gastric Adenocarcinoma Cell Lines.

Int J Mol Sci 2019;20(23):6077

109. Botlagunta M,Winnard P, Raman V: Neoplastic transformation of breast epithelial cells by genotoxic stress. BMC cancer 2010; 10:343

110. Tian H, Zhang N, Suo W-H, Wang T, Song L-J, Wu J, Liu Q, Shen W-W, Fu G-H: Gastrin suppresses the interdependent expression of p16 and anion exchanger 1 favoring growth inhibition of gastric cancer cells. International Journal of Cancer 2010;127(6):1462–1474

111. Song L J, Liu R J, Zeng Z, Alper S L, Cui H J, Lu Y, Zheng L, Yan Z W, Fu G H: Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK. J Mol Med 2012;90(6):707-718

112. Zu L-D, Peng X-C, Zeng Z, Wang J-L, Meng L-L, Shen W-W, Hu C-T, Yang Y, Fu G-H:Gastrin inhibits gastric cancer progression through activating the ERK-P65-miR23a/27a/24 axis. Journal of Experimental & Clinical Cancer Research 2018;37(1):115

113. Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Ogino S, Fujita Y, Hiramoto H, Hamada J, Shoda K, Kosuga T, Fujiwara H, Okamoto K, Otsuji E:

Tumor exosome-mediated promotion of adhesion to mesothelial cells in gastric cancer cells. Oncotarget 2016;7(35):56855-56863